Propiedad y actividad de insiders de Mirum Pharmaceuticals, Inc. (MIRM): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $97.37 |
| Capitalización | $5.9B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-02 | Howe Jolanda | S-Sale | 658 | $66K |
| 2026-09-01 | Peetz Christopher | M-Exempt | 30,000 | $88K |
| 2026-09-01 | Peetz Christopher | S-Sale | 8,312 | $815K |
| 2026-09-01 | Peetz Christopher | S-Sale | 21,688 | $2.1M |
| 2026-09-01 | Peetz Christopher | M-Exempt | 30,000 | $88K |
| 2026-08-18 | Howe Jolanda | M-Exempt | 40,000 | $251K |
| 2026-08-18 | Howe Jolanda | S-Sale | 40,000 | $4.0M |
| 2026-08-18 | Howe Jolanda | M-Exempt | 40,000 | $251K |
| 2026-08-11 | BJERKHOLT ERIC | S-Sale | 6,001 | $600K |
| 2026-08-10 | Peetz Christopher | M-Exempt | 20,000 | $59K |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $52.0M | $12.0M | $142.1M | $31.3M | $28.0M | $286.3M | $222.5M | $296.7M |
| Inversiones a Corto | 0 | $104.7M | $89.7M | $125.2M | $123.7M | 0 | $57.8M | $86.6M |
| Cuentas por Cobrar | 0 | 0 | 0 | $4.4M | $24.0M | $68.0M | $78.3M | $123.3M |
| Inventario | 0 | 0 | 0 | $1.5M | $5.6M | $22.3M | $22.4M | $24.9M |
| Activos Corrientes | $52.0M | $119.4M | $236.3M | $166.6M | $190.2M | $387.5M | $392.8M | $549.7M |
| Inmovilizado Material | 0 | $3.7M | $3.2M | $2.5M | $2.3M | $2.0M | $9.8M | $10.6M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $18.7M | $59.0M | $252.9M | $249.8M | $260.9M |
| Activos Totales | $52.0M | $146.7M | $240.9M | $294.7M | $352.9M | $646.6M | $670.8M | $842.8M |
| Cuentas por Pagar | $269000 | $3.4M | $3.2M | $9.2M | $8.7M | $7.4M | $14.6M | $9.6M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.4M | $13.1M | $18.5M | $42.6M | $64.7M | $87.1M | $126.6M | $205.8M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | $306.4M | $308.1M | $309.8M |
| Pasivos Totales | $62.3M | $16.4M | $68.8M | $174.4M | $210.9M | $398.0M | $445.1M | $528.1M |
| Reservas | -$17.3M | -$69.9M | -$173.2M | -$257.2M | -$392.8M | -$556.2M | -$644.2M | -$667.5M |
| Patrimonio Neto | -$10.3M | $130.3M | $172.1M | $120.2M | $142.0M | $248.7M | $225.6M | $314.7M |
| Deuda Total | 0 | $3.6M | $3.3M | $2.6M | $2.2M | $308.1M | $317.8M | $319.5M |
| Deuda Neta | -$52.0M | -$113.0M | -$228.6M | -$153.9M | -$149.5M | $21.8M | $37.4M | -$63.9M |
| Capital Circulante | $49.5M | $106.3M | $217.9M | $124.0M | $125.5M | $300.5M | $266.2M | $343.9M |
Salud financiera
| Deuda / Patrimonio | -72.97 |
| Ratio corriente | 2.86 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 4.42 |
Rentabilidad
| Rentabilidad sobre capital | -410.20% |
| Rentabilidad sobre capital invertido | -13.09% |
| Rentabilidad sobre activos | -82.32% |
| Margen bruto | 81.70% |
| Margen operativo | -17.42% |
| Margen neto | -139.18% |
Empresas relacionadas: ACAD · ADMA · BLTE · DYN · LGND · PRAX · RARE
Explorar sector: Healthcare · Biotechnology
Más secciones de MIRM: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones